ArticleMedicina (Kaunas, Lithuania)2022

Eribulin Mesylate Improves Cisplatin-Induced Cytotoxicity of Triple-Negative Breast Cancer by Extracellular Signal-Regulated Kinase 1/2 Activation.

Hyemi Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.